By
Drug Target Review2024-08-01T12:00:46
Organoids with SMA-pathology uncovered key findings about the disease, which could be utilised to develop new therapeutic options.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-11-20T13:43:43
Sponsored by Merck
2023-07-04T09:00:08
Sponsored by SB Drug Discovery
2024-02-01T11:52:50
Sponsored by Leica Microsystems
2023-02-13T11:57:11
Sponsored by Agilent
Site powered by Webvision Cloud